|
US4443340A
(en)
|
1981-10-09 |
1984-04-17 |
Betz Laboratories, Inc. |
Control of iron induced fouling in water systems
|
|
US5100899A
(en)
|
1989-06-06 |
1992-03-31 |
Roy Calne |
Methods of inhibiting transplant rejection in mammals using rapamycin and derivatives and prodrugs thereof
|
|
JPH04230389A
(ja)
|
1990-07-16 |
1992-08-19 |
American Home Prod Corp |
ラパマイシン誘導体
|
|
US5023262A
(en)
|
1990-08-14 |
1991-06-11 |
American Home Products Corporation |
Hydrogenated rapamycin derivatives
|
|
PT98990A
(pt)
|
1990-09-19 |
1992-08-31 |
American Home Prod |
Processo para a preparacao de esteres de acidos carboxilicos de rapamicina
|
|
US5145684A
(en)
|
1991-01-25 |
1992-09-08 |
Sterling Drug Inc. |
Surface modified drug nanoparticles
|
|
US5120842A
(en)
|
1991-04-01 |
1992-06-09 |
American Home Products Corporation |
Silyl ethers of rapamycin
|
|
US5120727A
(en)
|
1991-05-29 |
1992-06-09 |
American Home Products Corporation |
Rapamycin dimers
|
|
US5120725A
(en)
|
1991-05-29 |
1992-06-09 |
American Home Products Corporation |
Bicyclic rapamycins
|
|
IL102414A
(en)
|
1991-07-25 |
1996-08-04 |
Univ Louisville Res Found |
Medicinal preparations for the treatment of ocular inflammation, containing rapamycin
|
|
ES2139646T3
(es)
|
1991-12-19 |
2000-02-16 |
Mitsui Chemicals Inc |
Acido polihidroxido carboxilico y su procedimiento de obtencion.
|
|
US5177203A
(en)
|
1992-03-05 |
1993-01-05 |
American Home Products Corporation |
Rapamycin 42-sulfonates and 42-(N-carboalkoxy) sulfamates useful as immunosuppressive agents
|
|
US5242910A
(en)
|
1992-10-13 |
1993-09-07 |
The Procter & Gamble Company |
Sustained release compositions for treating periodontal disease
|
|
US5536729A
(en)
|
1993-09-30 |
1996-07-16 |
American Home Products Corporation |
Rapamycin formulations for oral administration
|
|
US5527907A
(en)
|
1993-11-19 |
1996-06-18 |
Abbott Laboratories |
Macrolide immunomodulators
|
|
US5968542A
(en)
|
1995-06-07 |
1999-10-19 |
Southern Biosystems, Inc. |
High viscosity liquid controlled delivery system as a device
|
|
DK1006935T3
(da)
|
1995-06-07 |
2005-06-06 |
Durect Corp |
Styret afgivelsessystem med en væske med höj viskositet
|
|
US5747058A
(en)
|
1995-06-07 |
1998-05-05 |
Southern Biosystems, Inc. |
High viscosity liquid controlled delivery system
|
|
US7833543B2
(en)
|
1995-06-07 |
2010-11-16 |
Durect Corporation |
High viscosity liquid controlled delivery system and medical or surgical device
|
|
US5989591A
(en)
|
1997-03-14 |
1999-11-23 |
American Home Products Corporation |
Rapamycin formulations for oral administration
|
|
US6015815A
(en)
|
1997-09-26 |
2000-01-18 |
Abbott Laboratories |
Tetrazole-containing rapamycin analogs with shortened half-lives
|
|
US6890546B2
(en)
|
1998-09-24 |
2005-05-10 |
Abbott Laboratories |
Medical devices containing rapamycin analogs
|
|
US6376517B1
(en)
|
1998-08-14 |
2002-04-23 |
Gpi Nil Holdings, Inc. |
Pipecolic acid derivatives for vision and memory disorders
|
|
AU2002242231B2
(en)
|
2001-02-23 |
2007-09-06 |
Genentech, Inc. |
Erodible polymers for injection
|
|
ATE419831T1
(de)
|
2002-07-31 |
2009-01-15 |
Alza Corp |
Injizierbare multimodale polymere depotzusammensetzungen und ihre verwendungen
|
|
ES2494791T3
(es)
|
2002-09-18 |
2014-09-16 |
Trustees Of The University Of Pennsylvania |
Uso de rapamicina para el tratamiento o prevención de la degeneración macular asociada a la edad
|
|
AU2003295409B2
(en)
|
2002-11-06 |
2010-02-11 |
Durect Corporation |
Controlled release depot formulations
|
|
ES2553136T3
(es)
|
2002-12-13 |
2015-12-04 |
Durect Corporation |
Sistema de administración oral de fármacos que comprende materiales vehículos líquidos de alta viscosidad
|
|
AU2004219595A1
(en)
|
2003-03-11 |
2004-09-23 |
Qlt Usa Inc. |
Formulations for cell- schedule dependent anticancer agents
|
|
CN102144961A
(zh)
|
2003-09-18 |
2011-08-10 |
参天制药株式会社 |
经巩膜递送
|
|
US7087237B2
(en)
|
2003-09-19 |
2006-08-08 |
Advanced Ocular Systems Limited |
Ocular solutions
|
|
KR101492361B1
(ko)
|
2004-09-17 |
2015-02-11 |
듀렉트 코퍼레이션 |
바람직하게 ｓａｉｂ와 같은 당 에스테르를 포함하는 지속적인 국소 마취제 조성물
|
|
KR101341359B1
(ko)
|
2004-10-01 |
2013-12-13 |
램스코르 인코포레이티드 |
편리하게 이식가능한 서방형 약물 조성물
|
|
US20080038316A1
(en)
|
2004-10-01 |
2008-02-14 |
Wong Vernon G |
Conveniently implantable sustained release drug compositions
|
|
US8313763B2
(en)
|
2004-10-04 |
2012-11-20 |
Tolmar Therapeutics, Inc. |
Sustained delivery formulations of rapamycin compounds
|
|
US8663639B2
(en)
*
|
2005-02-09 |
2014-03-04 |
Santen Pharmaceutical Co., Ltd. |
Formulations for treating ocular diseases and conditions
|
|
EP1853259A1
(en)
|
2005-02-09 |
2007-11-14 |
Macusight, Inc. |
Formulations for ocular treatment
|
|
JP2008533204A
(ja)
*
|
2005-03-21 |
2008-08-21 |
マクサイト， インコーポレイテッド |
病気又は症状の治療のためのドラッグ送達システム
|
|
US20070027105A1
(en)
|
2005-07-26 |
2007-02-01 |
Alza Corporation |
Peroxide removal from drug delivery vehicle
|
|
US8852638B2
(en)
|
2005-09-30 |
2014-10-07 |
Durect Corporation |
Sustained release small molecule drug formulation
|
|
EP2001438A2
(en)
|
2006-02-09 |
2008-12-17 |
Macusight, Inc. |
Stable formulations, and methods of their preparation and use
|
|
EP2001466B1
(en)
|
2006-03-23 |
2016-01-06 |
Santen Pharmaceutical Co., Ltd |
Low-dose rapamycin for the treatment of vascular permeability-related diseases
|
|
CN1973822A
(zh)
|
2006-12-20 |
2007-06-06 |
山东蓝金生物工程有限公司 |
一种含雷帕霉素的抗癌组合物
|
|
US20100184659A1
(en)
|
2006-12-21 |
2010-07-22 |
Warren Jaworowicz |
Sustained-Release Formulations Comprising Crystals, Macromolecular Gels, and Particulate Suspensions of Biologic Agents
|
|
AU2008254538B2
(en)
|
2007-05-18 |
2013-11-07 |
Durect Corporation |
Improved depot formulations
|
|
ES2507078T3
(es)
|
2007-08-16 |
2014-10-14 |
Santen Pharmaceutical Co., Ltd |
Formulaciones de rapamicina para tratamiento de la degeneración macular relacionada con la edad
|
|
AU2008347158B8
(en)
|
2007-12-06 |
2013-08-22 |
Durect Corporation |
Oral pharmaceutical dosage forms
|
|
JP5737949B2
(ja)
|
2008-02-08 |
2015-06-17 |
キューピーエス リミテッド ライアビリティ カンパニー |
薬物制御送達用の非ポリマー組成物
|
|
CA2760932A1
(en)
|
2009-05-04 |
2010-11-11 |
Thierry Nivaggioli |
Mtor pathway inhibitors for treating ocular disorders
|
|
EA026964B1
(ru)
|
2010-11-24 |
2017-06-30 |
Дьюрект Корпорейшн |
Биоразлагаемая композиция для доставки лекарственного средства (варианты)
|
|
WO2013078396A2
(en)
|
2011-11-23 |
2013-05-30 |
Durect Corporation |
Radiation-sterilized biodegradable drug delivery compositions
|
|
AU2013212583A1
(en)
|
2012-01-23 |
2014-08-14 |
Allergan, Inc. |
Time released biodegradable or bioerodible microspheres or microparticles suspended in a solidifying depot-forming injectable drug formulation
|
|
HK1220628A1
(zh)
*
|
2013-03-11 |
2017-05-12 |
Durect Corporation |
包含高粘度液体载体的可注射控制释放组合物
|
|
US9572885B2
(en)
|
2013-03-15 |
2017-02-21 |
Durect Corporation |
Compositions with a rheological modifier to reduce dissolution variability
|
|
JP2016514692A
(ja)
|
2013-03-15 |
2016-05-23 |
デュレクト コーポレーション |
チキソトロピーならびに強化された溶解再現性及び安定性を有する組成物
|
|
KR102245354B1
(ko)
|
2013-05-24 |
2021-04-30 |
아이콘 바이오사이언스, 인크. |
백내장 수술 후 염증에서의 서방출 덱사메타손의 용도
|
|
EP3220887A1
(en)
|
2014-11-21 |
2017-09-27 |
Technical University of Denmark |
Gel formulations for local drug release
|
|
WO2016148228A1
(ja)
|
2015-03-18 |
2016-09-22 |
参天製薬株式会社 |
徐放性医薬組成物
|
|
AR105215A1
(es)
|
2015-07-01 |
2017-09-13 |
Santen Pharmaceutical Co Ltd |
Formulación de depósito que contiene ésteres de ácido cítrico
|
|
JP7051721B2
(ja)
|
2016-06-30 |
2022-04-11 |
デュレクト コーポレーション |
デポー製剤
|
|
JP7030813B2
(ja)
|
2017-01-06 |
2022-03-07 |
参天製薬株式会社 |
前立腺癌の処置のためのシロリムスの腫瘍内投与
|